SCHEMBL8947064

SCHEMBL8947064

CCCCc1ccc(-c2ccc(CCCO)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 6/20 0.61
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
ALDH1A1 P00352 3/20 0.53
MEN1 O00255 1/20 0.53
RARA P10276 1/20 0.53
MAPT P10636 1/20 0.53
MTOR P42345 1/20 0.53
KMT2A Q03164 1/20 0.53
HSD17B10 Q99714 3/20 0.52
HPGD P15428 1/20 0.52
ESR1 P03372 2/20 0.50
ADRA2A P08913 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
TACR2 P21452 2/20 0.50
SLC6A2 P23975 2/20 0.50
SLC6A4 P31645 2/20 0.50
SLC6A3 Q01959 2/20 0.50
LMNA P02545 2/20 0.50
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3031498 0.93 CA2 (0.59) RARBCA1CA2ALDH1A1HSD17B10
SCHEMBL11894717 0.91 RARB (0.52) RARBCA1CA2ALDH1A1MEN1
SCHEMBL28829434 0.89 RARB (0.67) RARBCA1CA2ALDH1A1MEN1
SCHEMBL5551587 0.89 RARB (0.67) RARBCA1CA2ALDH1A1MEN1
SCHEMBL3535251 0.89 CA2 (0.54) RARBCA2ALDH1A1MEN1RARA
SCHEMBL8500578 0.86 ALDH1A1 (0.59) CA1CA2ALDH1A1HSD17B10HPGD
SCHEMBL6287871 0.86 ALDH1A1 (0.65) ALDH1A1MEN1KMT2AHSD17B10ESR1
SCHEMBL28900119 0.86 RARB (0.64) RARBCA1CA2ALDH1A1MEN1
SCHEMBL17193544 0.85 RARB (0.54) RARBALDH1A1MEN1RARAMAPT
SCHEMBL10001878 0.85 RARB (0.51) RARBCA1CA2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed